Computational dissection of tissue contamination for identification of colon cancer‐specific expression profiles
- 22 January 2003
- journal article
- Published by Wiley in The FASEB Journal
- Vol. 17 (3) , 376-385
- https://doi.org/10.1096/fj.02-0478com
Abstract
Microarray profiles of bulk tumor tissues reflect gene expression corresponding to malignant cells as well as to many different types of contaminating normal cells. In this report, we assess the feasibility of querying baseline multitissue transcriptome databases to dissect disease-specific genes. Using colon cancer as a model tumor, we show that the application of Boolean operators (AND, OR, BUTNOT) for database searches leads to genes with expression patterns of interest. The BUTNOT operator for example allows the assignment of "expression signatures" to normal tissue specimens. These expression signatures were then used to computationally identify contaminating cells within conventionally dissected tissue specimens. The combination of several logic operators together with an expression database based on multiple human tissue specimens can resolve the problem of tissue contamination, revealing novel cancer-specific gene expression. Several markers, previously not known to be colon cancer associated, are provided.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (TU 115/1-2)
This publication has 26 references indexed in Scilit:
- Genes Expressed in Human Tumor EndotheliumScience, 2000
- Detection of differentially expressed genes in lymphomas using cDNA arrays: identification of clusterin as a new diagnostic marker for anaplastic large-cell lymphomasBlood, 2000
- Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression MonitoringScience, 1999
- Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arraysProceedings of the National Academy of Sciences, 1999
- Gastrointestinal Carcinoma Antigen GA733: Target for Immunodestruction and Potential Modifier of Invasiveness and ChemoresponsivenessJNCI Journal of the National Cancer Institute, 1998
- Monoclonal antibody therapy for resected Dukes' C colorectal cancer: seven-year outcome of a multicenter randomized trial.Journal of Clinical Oncology, 1998
- Exploring the Metabolic and Genetic Control of Gene Expression on a Genomic ScaleScience, 1997
- Expression monitoring by hybridization to high-density oligonucleotide arraysNature Biotechnology, 1996
- Laser Capture MicrodissectionScience, 1996
- Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA MicroarrayScience, 1995